LeonaBio, Inc.

LONA

NasdaqBiological Products, (No Diagnostic Substances)WA

+4.1%

since IPO

IPO Price

$8.35

Current Price

$8.69

Return

+4.1%▲

Market Cap

$81.6M

IPO Date

Apr 2, 2026

Lockup End

Sep 29, 2026

Lockup Status

152days until lockup expires

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price

IPO Price

Lockup End

Performance Summary

First Day

N/A

1 Month

N/A

3 Months

N/A

6 Months

N/A

1 Year

N/A

Since IPO

+4.1%

LeonaBio, Inc. (LONA) — IPO Analysis

By Kian O Connor | Updated 4/30/2026

Company Overview

LeonaBio, Inc. (ticker: LONA) specializes in market positioning while maintaining strategic capabilities in customer service excellence, positioning itself within the Biological Products, (No Diagnostic Substances) sector through strategic positioning and niche market expertise. The company has developed its operations around operational excellence, creating market differentiation through specialized expertise and performance-based contracts that supports sustainable growth and customer relationship development. The company completed its public offering on 2026-04-02, accessing capital markets during economic environment adaptation within the Biological Products, (No Diagnostic Substances) landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to market positioning as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated positive market validation with ongoing investor evaluation of competitive positioning and execution capabilities. Market assessment focuses on the company's strategic positioning and strategic emphasis on customer service excellence as indicators of long-term competitive positioning within the Biological Products, (No Diagnostic Substances) sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires March 19, 2027, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on market positioning and emphasis on operational excellence, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Biological Products, (No Diagnostic Substances) market landscape.

Performance Overview

Since going public at $8.35 per share on Apr 2, 2026, LeonaBio, Inc. shares have gained 4.1%, rewarding investors who participated in the IPO. The stock currently trades at $8.69, giving the company a market capitalization of $81.6M.

Lockup Expiration

The lockup period for LeonaBio, Inc. insiders is set to expire on Sep 29, 2026, which is 152 days from now. When the lockup expires, insiders and early investors who received shares before the IPO will be free to sell their holdings on the open market. This can create significant selling pressure and is closely watched by traders and institutional investors alike.

Industry Context

LeonaBio, Inc. operates in the Biological Products, (No Diagnostic Substances) sector, which has seen varied IPO activity in recent years. The company is headquartered in WA and is classified under SIC code 2836. Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing LONA as an investment.

Trading History

LeonaBio, Inc. is actively trading in the public markets with a current share price of $8.69. The company went public at $8.35 per share, resulting in gains of 4.1% for IPO investors. With a current market capitalization of $81.6M, LeonaBio, Inc. continues to establish its presence as a publicly traded entity in the Biological Products, (No Diagnostic Substances).

Important Disclaimer

This analysis of LeonaBio, Inc. (LONA) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2

Pre-Expiry Average

Minimal

74

Expiry Day

High

55

Post-Expiry (30d)

High

Activity Heatmap

60 days before/after lockup expiry

Intensity Scale:

Minimal

Low

Moderate

High

Very High

Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Similar IPOs

Companies with similar industry, market cap, or IPO timing

Biological Products, (No Diagnostic Substances)

Same IndustrySame Exchange

COAG

Hemab Therapeutics Holdings, Inc.

N/A

return

Industry:

Biological Products, (No Diagnostic Substances)

Motor Vehicles & Passenger Car Bodies

Same ExchangeSimilar Size

JATT

JATT II Acquisition Corp.

Same ExchangeSimilar Size

Misc Industrial & Commercial Machinery & Equipment

Same ExchangeSimilar Size

RPGL

Republic Power Group Ltd

+45.4%

return

Industry:

Services-Prepackaged Software

Same ExchangeSimilar Size

Want to compare these IPOs side by side?

Compare Tool →

Related IPOs

Ticker	Company	Industry	IPO Date	IPO Price	Current	Return
SWRD	Stewards, Inc.	Short-Term Business Credit Institutions	Apr 28, 2026	$2.71	$2.60	-4.1%
COAG	Hemab Therapeutics Holdings, Inc.	Biological Products, (No Diagnostic Substances)	Apr 28, 2026	N/A	N/A	N/A
REA	Rare Earths Americas, Inc.	Metal Mining	Apr 28, 2026	N/A	N/A	N/A
QLEP	Quantum Leap Acquisition Corp	Blank Checks	Apr 28, 2026	N/A	N/A	N/A
ASFH	ASIAFIN HOLDINGS CORP.	Services-Business Services, NEC	Apr 28, 2026	$0.51	$0.51	+0.0%
GMRS	GMR Solutions Inc.	Transportation Services	Apr 28, 2026	N/A	N/A	N/A
IACQ	Irenic Acquisition Corp.	Blank Checks	Apr 28, 2026	N/A	N/A	N/A
CXII	Churchill Capital Corp XII	Blank Checks	Apr 28, 2026	N/A	N/A	N/A